We initiate coverage of Heijmans, a contractor focused on the Dutch market, with an Outperform rating and a TP of € 36.5 (DCF based). The Dutch residential market is finally recovering, and we believe Heijmans is well-positioned to benefit due to its land bank and property development arm, driving up revenues while EBITDA margins are expected to exceed 8.5% in the Living unit. Heijmans is also benefitting from strong demand from the infrastructure and energy markets, allowing for soli...
We initiate coverage of Heijmans, a contractor focused on the Dutch market, with an Outperform rating and a TP of € 36.5 (DCF based). The Dutch residential market is finally recovering, and we believe Heijmans is well-positioned to benefit due to its land bank and property development arm, driving up revenues while EBITDA margins are expected to exceed 8.5% in the Living unit. Heijmans is also benefitting from strong demand from the infrastructure and energy markets, allowing for soli...
>Upgrading to Outperform on better financial performance and valuation gap - We are upgrading our recommendation on Navigator from Neutral to Outperform and raising our TP from € 4.5 to € 5.0 (+11%: DCF, 7.5x implied EV/ EBITDA 2025e). Navigator’s share price has barely changed in 2024 despite the expected improvement in results and operating margins (EBITDA margin of 27.5% in 9M 2024 vs 25.7% in 2023) and their limited volatility across quarters thanks to the resili...
>Operating results in line with estimates, net profit slightly above - Navigator’s 9M 2024 results came out in line with our estimates with sales up by +7.4% and EBITDA up by +c.15% (-0.2% and +0.2% vs ODDOe respectively) and EBITDA margin of 27.5% (up 170bp on 9M 2023 and in line with our 27.4% estimate). Results reflect the traditional seasonal slowdown in paper demand (lower pulp/paper integration) and the declining trend in paper prices which explain the contracti...
We hosted our 4th ODDO BHF Iberian Forum on the 1st and 2nd of October 2024, virtually. In total, 63 companies were present. In the following note, we provide some initial feedback from the companies on day 2. - >ACS (=): good operating momentum maintained, Abertis and its dividends on the front page - Atresmedia (=): Q3 should be challenging but outlook reiterated - Befesa (=): zinc prices held up well, offsetting the negative impact of maintenance on Q3 volumes - CaixaBank ...
Oerlikon, leader in attractive niche markets with technology entry barriers, is about to enter the final chapter of its group transition into a Surface Solutions pure play via the planned separation of Polymer Processing Solutions (OPP) in the next 12-36 months. After the strong performance YTD, we are seeing no further significant upside from here for now. We are rating Oerlikon’s shares Neutral with a TP of CHF 5.2. - ...
Oerlikon, leader in attractive niche markets with technology entry barriers, is about to enter the final chapter of its group transition into a Surface Solutions pure play via the planned separation of Polymer Processing Solutions (OPP) in the next 12-36 months. After the strong performance YTD, we are seeing no further significant upside from here for now. We are rating Oerlikon’s shares Neutral with a TP of CHF 5.2. - ...
>EBITDA above estimates on strong cost efficiency - Strong results, significantly above our estimates (+18% in Q2 2024 EBITDA, +9% in H1) despite lower paper selling volumes thanks to good cash cost evolution (declines across segments between 6% and 14% in H1 2024), the positive evolution of demand and the price level of pulp, printing and packaging paper and tissue paper. Electricity sales also contracted (-28% vs H1 2023) as the CCTG in Setúbal is operating with onl...
En ligne avec les sondages, les élections au Parlement européen ont abouti à la déroute de la liste macroniste (14.5% des voix), loin derrière le Rassemblement national (31.5%). En réaction, le président français a dissous l’Assemblée nationale. Ce droit n’avait pas été exercé depuis 1997. Des élections anticipées auront lieu les 30 juin et 7 juillet. Dans une campagne extrêmement courte, tout laisse à croire que le RN sera le premier parti de la future Assemblée. En toute logique, le...
>Integrating recent acquisition in the UK’s tissue market - We are updating our estimates on Navigator after the successful acquisition of Accrol in the UK (one of the leading independent tissue converters for € 152m, 5% of the group’s market cap) with estimated sales of € 240m in 2024 (c.11% of Navigator’s 2024e sales). The transaction (EV of € c.220m, 9x EV/EBITDA LTM) strengthens its position in the attractive tissue market in Western Europe, particularly to the pr...
Growth momentum remains solid, and the publication of Q1 sales bodes well for the future (12.5% organic growth, including 27% for Aerospace). Margins are set to pick up in 2024 (by an estimated 110bp), with the underlying operating profit expected to jump 33%. With good visibility for Aerospace, medium-term potential for Automotive and profitable growth for Medical, we estimate the potential for margin improvement at no less than 500bp in the medium term. We are raising our underlying...
La dynamique de croissance reste solide et la publication du CA T1 est de bon augure (croissance organique de 12.5% dont 27% pour l’Aerospace). 2024 devrait voir un redressement des marges (+110 pb estimés) pour un ROC attendu en hausse de 33%. A l’appui d’une bonne visibilité pour l’aéronautique, d’un potentiel MT pour l’automobile et d’une croissance profitable pour le Médical, nous estimons le potentiel d’amélioration des marges à au moins 500 pb à MT. Nous relevons nos estimations...
>Resilient margins as volume increase offsets lower average prices - Navigator’s results came in line with estimates (EBITDA margin of c.25%) with sales growth (+7% y-o-y, +9% q-o-q) supported by strong volumes (+29% in paper and packaging products y-o-y and +10% q-o-q and c.+20% at pulp on both an annual and quarterly basis) as demand restocking in the uncoated wood free segment continued in Q1 2024 (+1.5% y-o-y apparent demand growth and +10.4% in Europe due to the ...
>Cash offer for leading tissue converter in the UK - Navigator has launched a public all-cash firm offer to acquire the entire issued and to-be-issued share capital of Accrol Group Holdings plc, a tissue paper converter based in the UK. Accrol’s Board of Directors is backing the offer which values the equity at € 148m (5% of Navigator’s market capitalisation) and the EV at € 180m (5.5% of Navigator’s EV) implying 10x EV/ EBITDA vs Navigator’s 6.5x. Sligh...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.